6505--Lamotrigine Immediate Release (IR) Tablets

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0004 for an unrestricted procurement for Lamotrigine Immediate Release (IR) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.

All unit of use packaging identified in the Schedule of Supplies, (Line items 5 and 7, 60 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Solicitation # 36E79725R0004 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about November 07, 2024, with a tentative closing date of November 21, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Ray Roldan. Questions can be emailed to Raymond.Roldan@va.gov.

The estimated annual requirements are as follows:Â Â

Â

REQUIREMENT DESCRIPTIONÂ

Item

Description

Package Size (Tablets per Bottle)

Total Estimated Annual Usage (Bottles)

1

Lamotrigine IR 25MG Tablets

100

13,751

2a

Lamotrigine IR 25MG Tablets

500

22,050

OR

OR

OR

OR

2b

Lamotrigine IR 25MG Tablets

1,000

11,025

3

Lamotrigine IR 100MG Tablets

100

22,283

4a

Lamotrigine IR 100MG Tablets

500

22,018

OR

OR

OR

OR

4b

Lamotrigine IR 100MG Tablets

1,000

11,009

5

Lamotrigine IR 150MG Tablets

60

43,824

6

Lamotrigine IR 150MG Tablets

500

10,704

7

Lamotrigine IR 200MG Tablets

60

45,951

8

Lamotrigine IR 200MG Tablets

500

19,124

Note: VA Clinicians will have the ability to continue to prescribe the branded product Lamictal; however, when Clinicians determine a generic is clinically appropriate the awarded product will be the mandatory source.